- We've seen multiple developments in Maverix's royalty portfolio thus far this year, with most having a positive impact on the company's long-term attributable production outlook.
- While the reduction in the TMAC royalty was a negative short-term, Karora's growth plans, the Roxgold/Fortuna merger, and Newcore PEA are positives.
- Maverix won't see the benefit of these developments immediately, but they have significantly strengthened the investment thesis, especially given that there's no buybacks on any of these projects.
- I continue to see Maverix as a solid buy-the-dip candidate, and I would view pullbacks below $4.95 as low-risk buying opportunities.
For further details see:
Maverix Metals: Recent Developments Strengthen Investment Thesis